جست‌وجوی استاد و پژوهشگر

Olivier Lichtargeمشاهده پروفایل

استاد

• Computational Biology
• Structural Biology
• Clinical Genomics
• +۸ مورد دیگر

Olivier Lichtarge, M.D., Ph.D. is the Cullen Chair and Professor at Baylor College of Medicine , with appointments in Molecular and Human Genetics, Biochemistry & Molecular Biology, and Pharmacology. He directs the Computational and Integrative Biomedical Research Center and co-directs the Structural & Computational Biology program. Education: BS (McGill), PhD & MD (Stanford), Residency & Fellowships (UCSF) Research: Integrates evolutionary principles with machine learning for multi-scale data analysis in Protein functional site prediction Mutation impact quantification Network diffusion for disease mechanism discovery Cognitive computing applications Key Contributions: Developed Evolutionary Trace and Action Equation methods, network compression schemes for cross-species analysis, and text-mining approaches for automated hypothesis generation. His work spans Alzheimer's disease , autism , cancer , and malaria research. Scientific Recognition: Fellow, AAAS (2019) Michael E. DeBakey Excellence in Research Award (2015) Raymond & Beverley Sackler Fellowship (2005) Basil O’Connor Award (2001) Multiple AHA Fellowships & Awards

• Skin Cancer Genetics
• Melanoma
• Cutaneous Oncology
• +۲ مورد دیگر

Dekker C. Deacon, MD, PhD, FAAD, serves as a Clinical Assistant Professor in the Department of Dermatology at the University of Utah, practicing at Huntsman Cancer Institute and University of Utah Hospital. He specializes in skin cancer treatment, particularly melanoma and cutaneous oncology, and provides comprehensive general dermatology care for conditions ranging from psoriasis to skin infections. As an active member of the Melanoma Disease Center, he participates in weekly multidisciplinary treatment planning conferences. His educational journey includes: Bachelor of Arts in Molecular Biology and Biochemistry from Middlebury College MD and PhD in Biomedical Sciences from University of California, San Diego (Medical Scientist Training Program) Internal Medicine Preliminary Internship at University of Utah School of Medicine Dermatology Residency and Chief Residency at University of Utah School of Medicine Dr. Deacon's research centers on skin cancer genetics, with emphasis on melanoma biomarkers and molecular mechanisms. His clinical work integrates cutting-edge genomic insights with patient care, focusing on early detection and personalized treatment strategies for skin malignancies. He treats diverse dermatological conditions while maintaining subspecialty expertise in complex oncology cases. Analysis of his 15 most recent publications reveals consistent focus on melanoma molecular subtypes (particularly acral and amelanotic variants), microRNA-based diagnostics, and novel therapeutic approaches including transdermal drug delivery systems. His work bridges genomic discovery with clinical translation, emphasizing tumor microenvironment interactions and ancestry-related genetic factors. Professional recognition includes: Fellow of the American Academy of Dermatology (FAAD) Dr. Deacon actively contributes to academic dermatology through clinical teaching and research mentorship within the residency program. His collaborative work with multidisciplinary oncology teams ensures comprehensive cancer care delivery. Patient testimonials consistently highlight his diagnostic expertise, compassionate communication, and effective treatment planning across both cancer and general dermatology contexts. He maintains active clinical-research integration through the Melanoma Disease Center at Huntsman Cancer Institute, working alongside surgical oncologists, medical oncologists, pathologists, and radiation specialists to develop individualized treatment protocols. His dual MD/PhD training enables unique contributions to translational research in skin cancer therapeutics.

• Genomics
• Proteomics
• Phenomics
• +۷ مورد دیگر

Bingjian Feng is a Researcher in the Department of Dermatology at the University of Utah . With a cross-disciplinary background in genetic epidemiology, bioinformatics, and software engineering, his work focuses on translational research in genomics, proteomics, and phenomics applied to cancers and autoimmune diseases. PhD : Erasmus University Rotterdam His research interests include: Development of bioinformatics and biostatistics tools for genome sequence analysis Clinical variant classification for cancer susceptibility genes (TP53, BRCA1/BRCA2) Multi-omics studies in head and neck cancer susceptibility Early detection of psoriatic arthritis in psoriasis patients Dr. Feng has developed key software tools like PERCH and VICTOR for variant interpretation, and his work on BayesDel scores is incorporated into ACMG guidelines. His publications span breast cancer, prostate cancer, head and neck cancer, psoriasis, and genetic risk modeling, with a focus on computational methods for variant analysis and cosegregation studies.

Catherine Goudieمشاهده پروفایل

استادیار

• cancer predisposition syndrome
• pediatric oncology
• genetics
• +۷ مورد دیگر

Catherine Goudie, MD, FRCPC is an Assistant Professor in the Department of Pediatrics at McGill University's Faculty of Medicine and Health Sciences, and a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site. She is affiliated with the Child Health and Human Development Program and the Centre for Outcomes Research and Evaluation (CORE), where she serves as a Pediatric Hematologist-Oncologist within the Department of Pediatrics, Division of Hematology at the MUHC. Dr. Goudie's research program centers on childhood cancer predisposition syndromes - genetic conditions that increase cancer risk throughout life. She has developed MIPOGG (McGill Interactive Pediatric OncoGenetic Guidelines), an eHealth decision-support tool containing 90 tumor-specific algorithms that use clinical, family history, and tumor features to determine genetic referral needs. Her work spans pediatric oncology, human genetics, eHealth implementation, health economics, and tumor surveillance protocols, with a particular focus on syndromes like Li-Fraumeni, DICER1, Constitutional Mismatch Repair Deficiency, and Gorlin syndrome. Recent publications demonstrate her leadership in genomic sequencing for pediatric cancer patients, TP53 variant classification, and cost-effectiveness analysis of genetic screening protocols. Dr. Goudie collaborates with clinicians and scientists worldwide to advance understanding of how cancer predisposition syndromes impact children's lives. Her research program offers training positions for Masters candidates interested in pediatrics, oncology, human genetics, eHealth, health policy, and economics. The Goudie Lab focuses on developing strategies to help doctors rapidly identify cancer predisposition syndromes in young patients, with ongoing work examining genetic variants in pediatric diffuse midline glioma, therapy-related subsequent cancers, and late-onset tumors in various predisposition syndromes.

• Metabolic Dysfunction
• Liver Disease
• Hepatology
• +۷ مورد دیگر

Professor Mohammed Eslam, an esteemed academic at the University of Sydney within the Faculty of Medicine and Health , is a global authority on metabolic dysfunction, liver disease, and liver cancer. His research has redefined fatty liver disease through international consensus, leading to the MAFLD (Metabolic Dysfunction-Associated Fatty Liver Disease) framework, which has been validated in over 10 million patients worldwide. He heads the International Liver Disease Genetics Consortium (7,000 samples across 13 countries) and serves as Deputy Director of the Storr Liver Centre . Research Focus: Genetics/epigenetics of liver diseases, fibrosis, personalized medicine, and translational studies Editorial Roles: Associate Editor for Sci Rep , Clin Exp Med , and Metab Target Organ Damage (2024-ongoing) Prominent Awards: Springer Nature Distinction Awards (2025), WISE Award (2015-2025), Turkish Society of Gastroenterology Symbolic Award (2024) His 15 most recent articles (2025-2024) span MAFLD epidemiology, genetic risk factors, fibrosis biomarkers (e.g., PRO-C3), and interdisciplinary approaches to chronic liver disease. Collaborations with global societies like APASL and AMAGE have influenced health policy. He mentors PhD students and examines theses internationally, focusing on lean MAFLD pathogenesis and splicing therapies. Scientific Honors: 2015-2025: Westmead Institute WISE Award (10 consecutive years) 2025: Springer Nature Editorial Contribution & Author Service Distinction 2024: Turkish Society of Gastroenterology Symbolic Award

• Oral pathology
• Oral cancer
• Cancer invasion and metastasis
• +۵ مورد دیگر

Dr. Marco Magalhaes is an Associate Professor at the University of Toronto's Faculty of Dentistry and serves as Graduate Program Director for Oral Pathology and Oral Medicine. He is a clinician-scientist with expertise in cancer cell biology, immunology, and clinical oral pathology. His professional affiliations include the University of Toronto's Faculty of Dentistry and Sunnybrook Health Science Centre where he works as a Staff Oral Pathologist. Dr. Magalhaes' research focuses on mechanisms of cancer invasion and metastasis, particularly invadopodia-dependent invasion in oral squamous cell carcinoma. His laboratory (CIMlab) investigates how specialized actin-rich structures mediate cancer cell invasion. He has published extensively on oral pathology, cancer mechanisms, and diagnostic challenges in oral lesions, with recent publications examining oral angioleiomyomas, plexiform ameloblastoma, and spatial transcriptomics of oral dysplasia. His research program is supported by multiple grants from CIHR, Cancer Research Society, and Canadian Cancer Society. Dr. Magalhaes earned his DDS from Universidade Federal de Goiás in Brazil, completed his PhD at the University of Toronto, and trained in cancer cell biology at Albert Einstein College of Medicine. He has received awards including the Wilson G. Harron Award and CIHR Strategic Training Fellowship. Dr. Magalhaes' scholarly work demonstrates consistent focus on understanding oral cancer mechanisms while addressing clinical diagnostic challenges in oral pathology. His recent publications show increasing emphasis on molecular mechanisms, tumor microenvironment, and translational applications for early cancer detection. As Graduate Program Director for Oral Pathology and Oral Medicine, he oversees advanced training in these specialties while maintaining an active research laboratory focused on cancer invasion mechanisms. His work bridges basic science and clinical practice, contributing to both scientific understanding and practical applications in oral cancer diagnosis and management.

Lucy A Godleyمشاهده پروفایل

استاد

• Cancer Genetics
• Hematology
• Oncology
• +۳ مورد دیگر

Lucy A Godley, MD, PhD, serves as the Jeffrey and Marianne Silver Family Professor of Oncology and Professor of Medicine in the Hematology and Oncology division at Northwestern University Feinberg School of Medicine. She is a physician-scientist actively affiliated with the Robert H. Lurie Comprehensive Cancer Center, where she conducts research and provides clinical care in hematologic malignancies. Educational background: BA: Harvard and Radcliffe Colleges (1988) PhD: University of California at San Francisco (1995) MD: Northwestern Feinberg School of Medicine (1997) Her research centers on the genetic architecture of blood cancers, with emphasis on germline variants in DDX41 and CHEK2 genes that drive hematopoietic malignancies. Through molecular biology and cancer genetics approaches, she investigates genome instability mechanisms, variant classification, and translation of findings into clinical risk assessment frameworks. Her work bridges laboratory discovery and patient care through implementation science initiatives. Analysis of recent publications reveals consistent focus on cancer genomics, particularly germline variant detection in tumor profiling and molecular mechanisms of genome integrity maintenance. Studies demonstrate how DDX41 resolves G-quadruplex structures to prevent cGAS-mediated cell death in erythroid cells, while CHEK2 variant research establishes new paradigms for leukemia predisposition syndromes. Scientific recognition includes: Nimmo Visiting Speaker, Royal Adelaide Hospital (2023) As a clinician-scientist, Dr. Godley leads translational research within the Lurie Cancer Center, mentoring trainees while developing clinical frameworks for genomic data integration. Her current initiatives address implementation challenges in bringing cancer genetics discoveries from bench to bedside, with emphasis on improving risk assessment and therapeutic strategies for blood cancer patients.

Allison L Goetschمشاهده پروفایل

استادیار

• Genetic Counseling
• Medical Genetics
• Genomics
• +۴ مورد دیگر

Allison L Goetsch serves as a Research Assistant Professor in the Department of Pediatrics (Genetics, Genomics, and Metabolism) at Northwestern University's Feinberg School of Medicine, with clinical affiliation at Ann & Robert H. Lurie Children's Hospital of Chicago. She is also affiliated with the Northwestern University Clinical and Translational Sciences Institute (NUCATS) and the Simpson Querrey Institute for Epigenetics. Her academic credentials include a Master of Science from Northwestern University (2014) and certification as a Genetic Counselor by the American Board of Genetic Counseling. Professional development is further evidenced by her active role in national and state genetic counseling organizations. Dr. Goetsch's research centers on clinical applications of genetic counseling in pediatric settings, with specialized expertise in neurofibromatosis , disorders of sex development , and expanded carrier screening . Her work integrates genomic technologies with patient education to address complex diagnostic and counseling challenges in inherited metabolic disorders and congenital conditions. Analysis of her 2020 publications reveals a consistent focus on translating genetic research into clinical practice, particularly through guideline development for neurofibromatosis counseling and evaluation of screening methodologies for conditions like hypospadias and fetal sex development disorders. These works demonstrate interdisciplinary collaboration across genetics, urology, and obstetrics. Her professional recognition includes: CodeTalker Award from the National Society of Genetic Counselors (2016) Constance Campbell Trainee Travel Award from Northwestern University (2014) Dr. Goetsch maintains significant leadership roles including current Presidency of the Illinois Society of Genetic Professionals (2017–Present) and active committee participation in the National Society of Genetic Counselors. Her service spans advocacy, practice guideline development, and conference planning for organizations including the Association for Glycogen Storage Disease and The Marfan Foundation, reflecting deep engagement in shaping genetic counseling standards and professional education.

• Musculoskeletal Pathology
• Bone Tumor Genetics
• Soft Tissue Sarcomas
• +۵ مورد دیگر

Professor Adrienne Flanagan is a distinguished academic in Musculoskeletal Pathology at University College London's Cancer Institute within the Department of Pathology. She practices clinical pathology at the Royal National Orthopaedic Hospital and serves as Meeting Secretary of the Pathological Society of Great Britain and Ireland, while also holding trustee positions with Sarcoma UK, The Jean Shanks Foundation, and The Chordoma Foundation (USA). Her educational background includes a Bachelor of Medicine from the Royal College of Surgeons in Ireland (1981) and a PhD from the University of London (1990), completed during her tenure as a Medical Research Council Training Fellow at St George's Hospital Medical School. Flanagan's research program centers on identifying genetic alterations in bone and soft tissue tumors, translating molecular findings into clinical diagnostics. She pioneered the discovery that brachyury expression serves as a universal diagnostic biomarker for chordoma, first reported IDH1/IDH2 mutations in cartilaginous tumors (linking them to Ollier and Maffucci syndromes), and identified recurrent H3F3 mutations in giant cell tumor of bone and chondroblastoma. Her work with the International Cancer Genome Consortium (2010-2015) established genomic landscapes for multiple bone tumor types. Her publications demonstrate consistent leadership in molecular tumor classification, with recent work spanning chromothripsis in osteosarcoma, HOX gene expression in spinal development, and AI-driven mitotic figure detection. Current research focuses on reclassifying tumors through molecular signatures to improve diagnostic accuracy and treatment stratification. Goudie Award for pathological science contributions (2017) William Gerald Award from Memorial Sloan Kettering Cancer Centre Senior NIHR Fellowship (2017) Flanagan maintains close collaboration with international patient advocacy groups and the Wellcome Trust Cancer Institute. Her clinical and research work directly informs diagnostic services through molecular-pathological correlation. She leads the Research Department of Pathology at UCL and contributes to national pathology training system development using digital pathology platforms.

Ahmet Sacanمشاهده پروفایل

استاد آموزشی

• Bioinformatics
• Structural Bioinformatics
• Imaging Informatics
• +۷ مورد دیگر

Ahmet Sacan is an Associate Teaching Professor at Drexel University's School of Biomedical Engineering, Science and Health Systems. His academic journey includes a PhD in Computer Engineering from Middle East Technical University (Turkey, 2008) and dual BSc degrees in Computer Science and Cellular and Molecular Biology from the University of Michigan (2001). His research spans the interdisciplinary fields of bioinformatics and biomedical engineering, with particular focus on: Structural Bioinformatics and protein structure analysis Imaging Informatics and automated cell tracking Genomic and proteomic database analysis Machine learning applications in biomarker discovery MicroRNA expression and target analysis Dr. Sacan's publication record demonstrates a strong trajectory in computational biology, with recent work increasingly focused on pain research, particularly inflammatory pain mechanisms and microRNA involvement in pain syndromes. His research shows a clear evolution from foundational bioinformatics tools development to more specialized applications in pain and cancer research. Among his notable scientific contributions are several widely used bioinformatics software tools including: CellTrack: An Open-Source Software for Cell Tracking and Motility Analysis LFM-Pro: A Tool for Detecting Significant Local Structural Sites in Proteins ImmunoTar: Integrative prioritization of cell surface targets for cancer immunotherapy MicroarrayDesigner: An online search tool for microarray experimental designs While currently holding a teaching position, Dr. Sacan is actively involved in research through co-advising graduate students in other labs at Drexel and neighboring institutions where research projects involve Bioinformatics analysis. His laboratory website indicates a focus on gene expression analysis, microRNA research, and machine learning applications in biomedical contexts.

• Cancer Genetics
• Genomics
• Uterine Leiomyomas
• +۳ مورد دیگر

Pia Vahteristo serves as a University Researcher at the University of Helsinki's Faculty of Medicine within the Department of Medical Genetics and Inherited Medicine. She leads the ATG - Applied Tumor Genomics research group and supervises doctoral candidates in the Biomedicine Programme. Her research centers on genomic mechanisms of gynecological disorders, particularly uterine leiomyomas and endometriosis. Using whole-genome and exome sequencing, she identifies molecular subtypes, chromosomal rearrangements (HMGA2/HMGA1/PLAG1), and driver mutations (MED12, NRF2 pathway). Current work focuses on translating genomic findings into clinical risk prediction models and personalized intervention strategies. Recent publications (2022-2025) reveal consistent genomic investigation of uterine tumors, with emerging themes in MED12 mutation impacts, surgical outcome correlations, and novel pathways like Cullin-3 neddylation defects. Her work bridges basic tumor genomics with clinical gynecology through multi-institutional collaborations. Dr. Vahteristo currently directs two major funded projects: the JAES initiative (2025-2028; €500,000 from Jane and Aatos Erkko Foundation) exploring tumor evolution, and a Cancer Foundation project (2023-2025; €120,000) investigating endometriosis genetics. As doctoral supervisor, she mentors next-generation researchers in genomic medicine. She operates within the ATG - Applied Tumor Genomics team, which specializes in integrating archival tissue analysis with cutting-edge sequencing technologies to decode gynecological tumor biology and improve diagnostic frameworks.

Matthew D Wilkersonمشاهده پروفایل

استاد

• Computational Biology
• Bioinformatics
• Data Science
• +۳ مورد دیگر

Dr. Matthew D Wilkerson serves as Professor of Anatomy, Physiology and Genetics at Uniformed Services University of the Health Sciences (USUHS) and Director of the Data Science Division within the Center for Military Precision Health (CMPH). His leadership drives computational analysis of genomic data across military health initiatives. Education: Postdoctoral Fellowship, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill Ph.D. in Bioinformatics and Computational Biology, Iowa State University B.S. in Biological Sciences, University of Notre Dame Dr. Wilkerson's research focuses on computational biology and cancer genomics, specializing in molecular subtype discovery for lung cancer and psychiatric conditions. His lab develops open-source tools for genome analysis while characterizing molecular profiles of cancer, inherited diseases, and environmental exposures through large-scale sequencing projects. Recent work spans proteogenomics of lung adenocarcinoma, psychiatric genomics in military populations, and clonal hematopoiesis in veterans, demonstrating strong interdisciplinary collaboration across military and civilian institutions. Key Awards: Henry C. Wu Award for Excellence in Basic Science Research (2025) Dean's Impact Award (2024) AACR Team Science Award (2020) Highly Cited Researcher (2019) As Director of CMPH's Data Science Division, Dr. Wilkerson oversees analysis of over 100,000 samples through the Collaborative Health Initiative Research Program. He leads the APOLLO Network's Data Analysis Working Group and maintains active roles at the John P. Murtha Cancer Center and Walter Reed National Military Medical Center. His laboratory's infrastructure enables hypothesis evaluation, phenotype analysis, and data management for military precision health initiatives.

Feng Cuiمشاهده پروفایل

دانشیار

• Artificial Intelligence
• Machine Learning
• Computational Biology
• +۴ مورد دیگر

Feng Cui is an Associate Professor in the Thomas H. Gosnell School of Life Sciences at Rochester Institute of Technology (RIT), where he serves as Graduate Director of the Bioinformatics MS Program and is an affiliated faculty member of the Golisano College for Computing and Information Sciences. He holds the position of Faculty Senator (Alternate) and maintains an active research laboratory focused on computational biology and bioinformatics. His educational background includes an MS from Truman State University, a Ph.D. in Bioinformatics and Computational Biology from Iowa State University, and an MD from Hunan Medical University in China. Following his doctoral studies, he completed postdoctoral training at the National Cancer Institute (NCI). Dr. Cui's research spans three primary areas: exploring nucleosomal DNA diversity, developing machine learning approaches to predict nucleosome-binding proteins, and applying artificial intelligence to medical and systems biology challenges. His work combines computational approaches with biological insights to address fundamental questions in chromatin structure and develop practical applications for disease diagnosis and treatment. His publication record from 2012-2023 demonstrates consistent output in high-impact journals including Nucleic Acids Research, BMC Bioinformatics, and Frontiers in Bioinformatics. His recent work shows a clear progression toward increasingly sophisticated AI applications in biology, with a growing emphasis on deep learning techniques for medical applications, particularly in cancer research and virology. Dr. Cui actively mentors students at multiple levels, with numerous undergraduate and graduate researchers contributing to his projects. His laboratory has been supported by funding from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health under award number R15GM149587. The Cui Research Group maintains a strong focus on the interface between computer science and biology, with current projects investigating nucleosomal DNA patterns, machine learning prediction of protein-DNA interactions, and AI applications for medical diagnostics. The lab has developed several computational tools including nuMap for nucleosome positioning prediction and ProtGauss for predicting nucleosome binding modes.

• Molecular genetics of prostate cancer
• Fibroblast growth factors
• Benign Prostatic Hyperplasia
• +۳ مورد دیگر

Michael M. Ittmann, M.D., Ph.D. is a Professor and William D. Tigertt Chair in Pathology at Baylor College of Medicine, where he also serves as Co-Leader of the Cancer Biology Program and Director of the Human Tissue Acquisition & Pathology Shared Resource at the Dan L Duncan Comprehensive Cancer Center. His research program focuses on molecular mechanisms of prostate cancer development and progression. Dr. Ittmann's research interests center on molecular genetics of prostate cancer , particularly investigating fibroblast growth factor signaling pathways, DNA methylation changes in prostate cancer, and racial disparities between African American and Caucasian prostate cancer patients. His laboratory has made significant contributions to understanding the role of FGFR signaling in prostate cancer progression and metastasis, as well as the biological significance of the TMPRSS2/ERG gene fusion. Dr. Ittmann's laboratory maintains active research funding from multiple sources including the Department of Defense Prostate Cancer Program and the Department of Veterans Affairs, with current projects focusing on enhancing radiation therapy outcomes, tumor microenvironment biomarkers in African American prostate cancer, and novel oncogenic pathways specific to African American prostate cancer. His leadership roles include serving as Co-Leader of the Cancer Biology Program at the Dan L Duncan Comprehensive Cancer Center and Director of the Human Tissue Acquisition & Pathology Shared Resource, which provides critical infrastructure for prostate cancer research at Baylor College of Medicine.

• Decision Theory
• Social Choice Theory
• Multicriteria Decision Making
• +۴ مورد دیگر

Olivier Cailloux serves as a Lecturer at LAMSADE (Laboratoire d'Analyse et Modélisation de Systèmes pour l'Aide à la Décision) within Université Paris-Dauphine, part of PSL University. His academic career spans computer science and decision theory, with significant contributions to the Decision Deck project as a founding member. This open-source initiative provides practical tools for decision-making methodology practitioners and educators. Cailloux's research expertise centers on decision theory and social choice, with particular emphasis on classification aggregation, voting systems, and multicriteria analysis. His work bridges theoretical foundations with practical applications, ranging from economic design principles to bioinformatics implementations. The interdisciplinary nature of his research is evident in collaborations spanning economics, computer science, and molecular biology, particularly in genomic analysis of the BRCA1 gene. His publications demonstrate a consistent focus on formal frameworks for deliberated judgment and robust decision support systems. Analysis of Cailloux's publication record reveals strong trends in computational social choice and decision support methodologies. His recent work (2023-2024) focuses on classification aggregation without unanimity requirements, representing cutting-edge developments in social choice theory. Earlier contributions established foundations for preference modeling with incomplete information and formal frameworks for deliberated judgment. His interdisciplinary approach is particularly notable in bioinformatics applications where decision theory principles are applied to genomic analysis. Cailloux maintains active research collaborations across multiple institutions, as evidenced by his co-authored publications with researchers from diverse fields. His work with the Decision Deck project demonstrates commitment to creating accessible, open-source tools for both academic and practical applications of decision science. The laboratory environment at LAMSADE provides a fertile ground for his interdisciplinary research, connecting theoretical computer science with real-world decision challenges.